, 2.1% ADAM) led to an
early disadvantage in survival. The investigators found
no statistically signiÔ¨Åcant difference in long-term
survival between the immediate OSR and surveillance
groups. Currently, nearly 80% of all AAAs are treated
by EVAR in the United States.276,277 Given the less invasive nature of EVAR, two studies re-evaluated the
appropriateness of intervention for small an